Literature DB >> 18480445

Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2.

Walter Lucchesi1, Gareth Brady, Oliver Dittrich-Breiholz, Michael Kracht, Rainer Russ, Paul J Farrell.   

Abstract

A transfection assay with a lymphoblastoid cell line infected with Epstein-Barr virus was used to compare the abilities of type 1 and type 2 EBNA2 to sustain cell proliferation. The reduced proliferation in cells expressing type 2 EBNA2 correlated with loss of expression of some cell genes that are known to be targets of type 1 EBNA2. Microarray analysis of EBNA2 target genes identified a small number of genes that are more strongly induced by type 1 than by type 2 EBNA2, and one of these genes (CXCR7) was shown to be required for proliferation of lymphoblastoid cell lines. The Epstein-Barr virus LMP1 gene was also more strongly induced by type 1 EBNA2 than by type 2, but this effect was transient. Type 1 and type 2 EBNA2 were equally effective at arresting cell proliferation of Burkitt's lymphoma cell lines lacking Epstein-Barr virus and were also shown to cause apoptosis in these cells. The results indicate that differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2 may be the basis for the much weaker B-cell transformation activity of type 2 Epstein-Barr virus strains compared to type 1 strains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480445      PMCID: PMC2493322          DOI: 10.1128/JVI.00223-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function.

Authors:  Eamon M McCann; Gemma L Kelly; Alan B Rickinson; Andrew I Bell
Journal:  J Gen Virol       Date:  2001-12       Impact factor: 3.891

2.  PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.

Authors:  A Sjöblom; A Jansson; W Yang; S Laín; T Nilsson; L Rymo
Journal:  J Gen Virol       Date:  1995-11       Impact factor: 3.891

3.  Histone acetylation and reactivation of Epstein-Barr virus from latency.

Authors:  P J Jenkins; U K Binné; P J Farrell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus.

Authors:  A V Gordadze; R Peng; J Tan; G Liu; R Sutton; B Kempkes; G W Bornkamm; P D Ling
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2.

Authors:  D Y Wu; A Krumm; W H Schubach
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  The ADAMDEC1 (decysin) gene structure: evolution by duplication in a metalloprotease gene cluster on chromosome 8p12.

Authors:  Elizabeth E M Bates; Wolf H Fridman; Chris G F Mueller
Journal:  Immunogenetics       Date:  2002-03-16       Impact factor: 2.846

7.  The human SNF5/INI1 protein facilitates the function of the growth arrest and DNA damage-inducible protein (GADD34) and modulates GADD34-bound protein phosphatase-1 activity.

Authors:  Daniel Y Wu; Douglas C Tkachuck; Rachel S Roberson; William H Schubach
Journal:  J Biol Chem       Date:  2002-05-16       Impact factor: 5.157

8.  Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.

Authors:  D Y Wu; G V Kalpana; S P Goff; W H Schubach
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.

Authors:  Gemma Kelly; Andrew Bell; Alan Rickinson
Journal:  Nat Med       Date:  2002-09-03       Impact factor: 53.440

Review 10.  Epstein-Barr virus and Burkitt lymphoma.

Authors:  G Brady; G J MacArthur; P J Farrell
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

View more
  36 in total

1.  Potentiation of EBV-induced B Cell transformation by CXCR4-tropic, but not CCR5-tropic, HIV gp120: implications for HIV-associated lymphomagenesis.

Authors:  Sujatha Iyengar; David H Schwartz
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

2.  ADAMDEC1 is a metzincin metalloprotease with dampened proteolytic activity.

Authors:  Jacob Lund; Ole H Olsen; Esben S Sørensen; Henning R Stennicke; Helle H Petersen; Michael T Overgaard
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

3.  A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2.

Authors:  Stelios Tzellos; Paulo B Correia; Claudio Elgueta Karstegl; Laila Cancian; Julian Cano-Flanagan; Michael J McClellan; Michelle J West; Paul J Farrell
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

4.  The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene.

Authors:  Pegah Johansson; Ann Jansson; Ulla Rüetschi; Lars Rymo
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

5.  Evidence for restricted reactivity of ADAMDEC1 with protein substrates and endogenous inhibitors.

Authors:  Jacob Lund; Linda Troeberg; Henrik Kjeldal; Ole H Olsen; Hideaki Nagase; Esben S Sørensen; Henning R Stennicke; Helle H Petersen; Michael T Overgaard
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

6.  Epstein-Barr virus genetic variants are associated with multiple sclerosis.

Authors:  Rosella Mechelli; Caterina Manzari; Claudia Policano; Anita Annese; Ernesto Picardi; Renato Umeton; Arianna Fornasiero; Anna Maria D'Erchia; Maria Chiara Buscarinu; Cristina Agliardi; Viviana Annibali; Barbara Serafini; Barbara Rosicarelli; Silvia Romano; Daniela F Angelini; Vito A G Ricigliano; Fabio Buttari; Luca Battistini; Diego Centonze; Franca R Guerini; Sandra D'Alfonso; Graziano Pesole; Marco Salvetti; Giovanni Ristori
Journal:  Neurology       Date:  2015-03-04       Impact factor: 9.910

7.  Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma.

Authors:  Jacob Lund; Anne Mette Elimar Bitsch; Morten Grønbech Rasch; Mari Enoksson; Linda Troeberg; Hideaki Nagase; Mette Loftager; Michael Toft Overgaard; Helle Heibroch Petersen
Journal:  MAbs       Date:  2017-11-29       Impact factor: 5.857

Review 8.  The role of stromal-derived factor-1--CXCR7 axis in development and cancer.

Authors:  Radoslaw B Maksym; Maciej Tarnowski; Katarzyna Grymula; Joanna Tarnowska; Marcin Wysoczynski; Riu Liu; Boguslaw Czerny; Janina Ratajczak; Magda Kucia; Mariusz Z Ratajczak
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

9.  Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.

Authors:  Robert E White; Ian J Groves; Ernest Turro; Jade Yee; Elisabeth Kremmer; Martin J Allday
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

10.  Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.

Authors:  Gareth Brady; Hannah J Whiteman; Lindsay C Spender; Paul J Farrell
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.